MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer Research

MC0704 is a STAT3 inhibitor (IC50=2.13 μM), which can be used for the research of metastatic triple-negative breast cancer (mTNBC).

Palbociclib is an Orally Active CDK4 and CDK6 Inhibitor for Cancer

Deguelin, a Naturally Occurring Rotenoid, Acts as a Chemopreventive Agent

SD-1029 is a JAK2/STAT3 Activation Inhibitor

6RK73 is a Covalent Irreversible and Specific UCHL1 Inhibitor

GN25 is a Specific p53-Snail Binding Inhibitor with Antitumor Effects

MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer

Small molecule agents for triple negative breast cancer: Current

SOR-C13 is a High-Affinity TRPV6 Antagonist for Advanced Solid

Cancers, Free Full-Text

RA375, a RPN13 Inhibitor, Activates UPR Signaling, ROS Production and Apoptosis

Ganitumab (AMG 479) is an IGF1R mAb for Cancer Research

PDF) Antitumor Activity of Pulvomycin via Targeting Activated

Blogs MedChemExpress

IPR-803 is a Potent Inhibitor of the uPAR•uPA Protein-Protein Interaction